Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome sequencing as a platform for pharmacogenetic genotyping: a pediatric cohort study
Iris Cohn, Tara Paton, Christian R. Marshall, et al.
npj Genomic Medicine (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

PharmVar GeneFocus: CYP2B6
Zeruesenay Desta, Ahmed El‐Boraie, Li Gong, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 1, pp. 82-97
Open Access | Times Cited: 214
PharmVar GeneFocus: CYP2D6
Charity Nofziger, Amy Turner, Katrin Sangkuhl, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 107, Iss. 1, pp. 154-170
Open Access | Times Cited: 186
Pharmacogenomics: current status and future perspectives
Munir Pirmohamed
Nature Reviews Genetics (2023) Vol. 24, Iss. 6, pp. 350-362
Closed Access | Times Cited: 160
Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease
Christian R. Marshall, Shimul Chowdhury, Ryan J. Taft, et al.
npj Genomic Medicine (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 110
Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges
Catriona Hippman, Corey Nislow
Journal of Personalized Medicine (2019) Vol. 9, Iss. 3, pp. 40-40
Open Access | Times Cited: 82
Targeted next generation sequencing as a tool for precision medicine
Markus Gulilat, Tyler Lamb, Wendy A. Teft, et al.
BMC Medical Genomics (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 77
Next-generation sequencing in pharmacogenomics – fit for clinical decision support?
Yitian Zhou, Volker M. Lauschke
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 213-223
Open Access | Times Cited: 9
Genome Sequencing as a Diagnostic Test in Children With Unexplained Medical Complexity
Gregory Costain, Susan Walker, Maria Marano, et al.
JAMA Network Open (2020) Vol. 3, Iss. 9, pp. e2018109-e2018109
Open Access | Times Cited: 66
The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants
Miriam S. Reuter, Susan Walker, Bhooma Thiruvahindrapuram, et al.
Canadian Medical Association Journal (2018) Vol. 190, Iss. 5, pp. E126-E136
Open Access | Times Cited: 59
Technologies for Pharmacogenomics: A Review
Maaike van der Lee, Marjolein Kriek, Henk‐Jan Guchelaar, et al.
Genes (2020) Vol. 11, Iss. 12, pp. 1456-1456
Open Access | Times Cited: 55
Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
Alireza Tafazoli, Henk‐Jan Guchelaar, Wojciech Miltyk, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 44
Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
Marwan K. Tayeh, Andrea Gaedigk, Matthew P. Goetz, et al.
Genetics in Medicine (2022) Vol. 24, Iss. 4, pp. 759-768
Open Access | Times Cited: 36
Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting
Iris Cohn, Roozbeh Manshaei, Eriskay Liston, et al.
JAMA Network Open (2021) Vol. 4, Iss. 5, pp. e2110446-e2110446
Open Access | Times Cited: 36
Pharmacogenomic testing in paediatrics: Clinical implementation strategies
Charlotte Barker, Gabriella Groeneweg, Anke H. Maitland‐van der Zee, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 10, pp. 4297-4310
Open Access | Times Cited: 35
Review on application and development of pharmacogenomics of adverse drug reactions
Hongyun Bi, Jun Zhu, Yuanxuan Cai, et al.
Journal of Holistic Integrative Pharmacy (2025) Vol. 6, Iss. 1, pp. 105-116
Open Access
Potential of Whole-Genome Sequencing-Based Pharmacogenetic Profiling
Sylvan M. Caspar, Timo Schneider, Patricia Stoll, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 3, pp. 177-190
Open Access | Times Cited: 27
Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray
Robin Z. Hayeems, Jasmin Bhawra, Kate Tsiplova, et al.
European Journal of Human Genetics (2017) Vol. 25, Iss. 12, pp. 1303-1312
Open Access | Times Cited: 37
Accurately Genotyping CYP2D6 : Not for the Faint of Heart
Charity Nofziger, Markus Paulmichl
Pharmacogenomics (2018) Vol. 19, Iss. 13, pp. 999-1002
Open Access | Times Cited: 33
Use of Pharmacogenetic Drugs by the Dutch Population
Mohammad A. Alshabeeb, Vera H.M. Deneer, Amjad Khan, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 31
A call for increased inclusivity and global representation in pharmacogenetic testing
April Kennedy, Gabriel Ma, Roozbeh Manshaei, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population
Ewa Goljan, Mohammed Abouelhoda, Mohamed El-Kalioby, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0263137-e0263137
Open Access | Times Cited: 12
Drug–Drug–Gene Interactions in Cardiovascular Medicine
Innocent G. Asiimwe, Munir Pirmohamed
Pharmacogenomics and Personalized Medicine (2022) Vol. Volume 15, pp. 879-911
Open Access | Times Cited: 12
Trio genome sequencing for developmental delay and pediatric heart conditions: A comparative microcost analysis
Jathishinie Jegathisawaran, Kate Tsiplova, Robin Z. Hayeems, et al.
Genetics in Medicine (2022) Vol. 24, Iss. 5, pp. 1027-1036
Open Access | Times Cited: 9
Variant Discovery Using Next-Generation Sequencing and its Future Role in Pharmacogenetics
Laura Russell, Ute I. Schwarz
Pharmacogenomics (2020) Vol. 21, Iss. 7, pp. 471-486
Closed Access | Times Cited: 13
Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: further evidence of validity
Robin Z. Hayeems, Stephanie Luca, Anna Hurst, et al.
European Journal of Human Genetics (2022) Vol. 30, Iss. 12, pp. 1423-1431
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top